| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/27/2005 | CN1646688A Growth regulating proteins |
| 07/27/2005 | CN1646567A Anti-idiotype anti-CEA antibody molecules and its use as cancer vaccine |
| 07/27/2005 | CN1646564A 修饰的因子Ⅷ Modification factor Ⅷ |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646562A Pluripotency determining factors and uses thereof |
| 07/27/2005 | CN1646558A Histone deacetylase inhibitors and process for producing the same |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646174A Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/27/2005 | CN1646167A Treatment of metabolic syndrome |
| 07/27/2005 | CN1646166A Method and composition for potentiating an opiate analgesic |
| 07/27/2005 | CN1646165A Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/27/2005 | CN1646163A Administration of agents for the treatment of inflammation |
| 07/27/2005 | CN1646162A Use of an inhibitor or antagonist against tissue factor |
| 07/27/2005 | CN1646159A Immunoadjuvant |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646153A Active antiangiogenic therapy |
| 07/27/2005 | CN1646152A Mannose binding lectin and uses thereof |
| 07/27/2005 | CN1646145A Preparations for topical skin use and treatment |
| 07/27/2005 | CN1646137A Method for treating and preventing hyperparathyroidism |
| 07/27/2005 | CN1646103A 高药物载荷片剂 High drug load tablets |
| 07/27/2005 | CN1646097A Chemosensitizing with liposomes containing oligonucleotides |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1646080A Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation |
| 07/27/2005 | CN1646026A Cheese capable of disinfecting helicobacter pylori |
| 07/27/2005 | CN1646020A Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
| 07/27/2005 | CN1644697A Thioredoxin peroxidase gene of China Qingdao branchiostoma and use thereof |
| 07/27/2005 | CN1644693A Protein having tpo activity |
| 07/27/2005 | CN1644692A Hippocampus protease inhibitor gene and its use |
| 07/27/2005 | CN1644586A Oxydiertes thymosin beta 4 |
| 07/27/2005 | CN1644214A YG and YGG used as maintenance and improvement of immunoreaction |
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212335C ICE hibiting peptides |
| 07/27/2005 | CN1212334C Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use |
| 07/27/2005 | CN1212155C CD 40 binding molecules and CTL peptides for treating tumors |
| 07/27/2005 | CN1212152C Tumor necrosis factor antagonists and their use in endometriosis |
| 07/27/2005 | CA2494384A1 A segment of glycosylation-deficient hgf alpha-chain |
| 07/26/2005 | US6921814 For detecting mutations and polymorphisms in torsin genemedical diagnosis |
| 07/26/2005 | US6921813 Comprises subunit of RNA polymerase holoenzyme which confers promoter sequence recognition and initiation of transcription for designing drugs to prevent mycobacterium infections; gene expression inhibition |
| 07/26/2005 | US6921808 Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc-globulin and a Gc-globulin medicinal product |
| 07/26/2005 | US6921805 Neo-tryptophan-containing neurotension polypeptide analogs having enhanced biological effects as compared to NT itself; antinociception/anorexogenic agents; induction of thirst, hypothermia, weight loss, appetite; psychological disorders |
| 07/26/2005 | US6921771 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione or pharmaceutically acceptable salts |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921758 Amino acid derivatives |
| 07/26/2005 | US6921751 Immunoregulator |
| 07/26/2005 | US6921750 A polypeptide produced by the parathyroid glands using such analogues alone or in combination with a bisphosphonate or calcitonin to treat osteoporosis |
| 07/26/2005 | US6921749 Polypeptides derived from endostatin exhibiting antiangiogenic activity |
| 07/26/2005 | US6921748 Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes |
| 07/26/2005 | US6921664 Telomerase |
| 07/26/2005 | US6921649 Comprises receptor polypeptide associated with energy balance for diagnosis and treatment of arteriolosclerosis and inflammatory disorders |
| 07/26/2005 | US6921645 Antibodies to chemokine β-4 |
| 07/26/2005 | US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 07/26/2005 | US6921542 Preparation of a therapeutic composition |
| 07/26/2005 | US6921538 Administering neurotoxin; injecting into brains; side effect reduction |
| 07/26/2005 | US6921536 Lawsonia intracellularis vaccine |
| 07/26/2005 | US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain |
| 07/26/2005 | US6921531 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy |
| 07/26/2005 | US6921528 Highly efficient delivery of a large therapeutic mass aerosol |
| 07/26/2005 | US6921527 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery |
| 07/26/2005 | US6921526 Gastrin receptor-avid peptide conjugates |
| 07/26/2005 | CA2294562C Hepatitis c inhibitor peptide analogues |
| 07/26/2005 | CA2173611C Method of treating depressed reticuloendothelial system function |
| 07/26/2005 | CA2076961C Igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use |
| 07/26/2005 | CA2005567C Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| 07/22/2005 | CA2455659A1 Barhl2 proteins, genes encoding the same and uses thereof |
| 07/21/2005 | WO2005066867A2 Modulators of cell-surface receptors of the ig-class |
| 07/21/2005 | WO2005066629A1 Retinal toxicity screening methods |
| 07/21/2005 | WO2005066371A2 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 07/21/2005 | WO2005066337A2 Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation |
| 07/21/2005 | WO2005066334A1 Phosphokinase and the usage thereof |
| 07/21/2005 | WO2005066207A1 Glucagon-like peptide-1 analogs with long duration of action |
| 07/21/2005 | WO2005066206A1 Tnf antagonists and tnf inhibitors comprising the same as the active ingredient |
| 07/21/2005 | WO2005066205A2 Antiviral compositions which inhibit paramyxovirus infection |
| 07/21/2005 | WO2005066204A2 Neutralizing epitope-based growth enhancing vaccine |
| 07/21/2005 | WO2005066200A1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 07/21/2005 | WO2005066123A1 Protease inhibitors |
| 07/21/2005 | WO2005065722A2 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 07/21/2005 | WO2005065721A2 Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex |
| 07/21/2005 | WO2005065719A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | WO2005065718A2 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 07/21/2005 | WO2005065714A1 Intranasal administration of glucose-regulating peptides |
| 07/21/2005 | WO2005065711A2 Mammalian receptor proteins; related reagents and methods |
| 07/21/2005 | WO2005065706A1 Pharmaceutical composition for thrombin peptide derivatives |
| 07/21/2005 | WO2005065704A1 Preventive and remedy for bone disease |
| 07/21/2005 | WO2005065703A1 Novel use of ligand to gpr103-like receptor protein |
| 07/21/2005 | WO2005065702A1 Novel use of ligand to gpr103-like receptor protein |
| 07/21/2005 | WO2005065697A1 Method for the photostabilisation of phycobiliproteins in an aqueous extract, compositions containing stabilised phycobiliproteins and use of stabilised phycobiliproteins |
| 07/21/2005 | WO2005065308A2 Compositions and methods to treat recurrent medical conditions |
| 07/21/2005 | WO2005065121A2 Methods and compositions for the production of monoclonal antibodies |
| 07/21/2005 | WO2005065079A2 Medical implants and fibrosis-inducing agents |
| 07/21/2005 | WO2005065017A2 Methods of inducing il-10 production |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2005056027A3 Solvent for biogenic active pharmaceutical ingredients |
| 07/21/2005 | WO2005049012A3 Tryptophan for use in promoting and maintaining abstinence |
| 07/21/2005 | WO2005047455A3 Methods for the production of apolipoproteins in transgenic plants |
| 07/21/2005 | WO2005045039A9 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/21/2005 | WO2005042018A3 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/21/2005 | WO2005041873A3 Formulation of exendin-4 |
| 07/21/2005 | WO2005035547A3 E2f oligonucleotide decoy molecules |
| 07/21/2005 | WO2005032467A3 Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions |
| 07/21/2005 | WO2005016366A3 Method to inhibit the propagation of an undesired cell population |